Canadian Reimbursement and Forecasting Timelines (CRaFT) Report

April 2021 Edition

Market access professionals needcredible projections.

The Canadian Reimbursement and Forecasting Timelines Report provides credible, relevant inputs to help meet your reimbursement forecasting needs.

FEEDBACK ON THIS REPORT

WHAT IS THIS REPORT?

The Canadian Reimbursement and Forecasting Timelines Report April 2021 edition is a 90+ page PowerPoint resource complete with analysis and insights from trusted industry experts.

WHO WOULD BENEFIT?

Market access professionals interested in seeking meaningful inputs into internal reimbursement forecasting analyses.

WHY THIS REPORT?

MORSE analyzed Canadian market access data to create key reimbursement metrics. The Report can support any organization forecasting or planning a Canadian launch by providing critical insights on the public market reimbursement process – from HTA submission to provincial listing.

WHAT DOES THE REPORT INCLUDE?

  • Analysis of pCPA process phase timelines
  • Negotiation trends
  • Provincial time-to-listing trends and market access timelines
  • Sub-analysis of data with stratification by oncology & non-oncology
  • CADTH and pCPA volume metrics
  • pCPA Developments

WHAT TIME PERIOD DOES IT COVER?

The Report focuses on metrics from 2020 but also provides relevant comparisons to 2019 and 2018 to identify trends. Also, it contains formulary listing dates of 2019 & 2020 pCPA Completed Negotiations current as of April 1, 2021.

SNAPSHOT OF THE 2020 HIGHLIGHTS

For further information on content and pricing, please complete the form below.

This report is only available to pharmaceutical companies to assist with their reimbursement forecasting and planning.


We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

Canadian Reimbursement and Forecasting Timelines Report, April 2021 Edition